BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25539817)

  • 1. Cutting edge: critical role for C5aRs in the development of septic lymphopenia in mice.
    Grailer JJ; Fattahi F; Dick RS; Zetoune FS; Ward PA
    J Immunol; 2015 Feb; 194(3):868-72. PubMed ID: 25539817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of complement C5a and histones in septic cardiomyopathy.
    Fattahi F; Frydrych LM; Bian G; Kalbitz M; Herron TJ; Malan EA; Delano MJ; Ward PA
    Mol Immunol; 2018 Oct; 102():32-41. PubMed ID: 29914696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of extracellular histones in the cardiomyopathy of sepsis.
    Kalbitz M; Grailer JJ; Fattahi F; Jajou L; Herron TJ; Campbell KF; Zetoune FS; Bosmann M; Sarma JV; Huber-Lang M; Gebhard F; Loaiza R; Valdivia HH; Jalife J; Russell MW; Ward PA
    FASEB J; 2015 May; 29(5):2185-93. PubMed ID: 25681459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement-induced activation of MAPKs and Akt during sepsis: role in cardiac dysfunction.
    Fattahi F; Kalbitz M; Malan EA; Abe E; Jajou L; Huber-Lang MS; Bosmann M; Russell MW; Zetoune FS; Ward PA
    FASEB J; 2017 Sep; 31(9):4129-4139. PubMed ID: 28572445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanoma.
    Nabizadeh JA; Manthey HD; Panagides N; Steyn FJ; Lee JD; Li XX; Akhir FNM; Chen W; Boyle GM; Taylor SM; Woodruff TM; Rolfe BE
    FASEB J; 2019 Oct; 33(10):11060-11071. PubMed ID: 31298935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction.
    Niederbichler AD; Hoesel LM; Westfall MV; Gao H; Ipaktchi KR; Sun L; Zetoune FS; Su GL; Arbabi S; Sarma JV; Wang SC; Hemmila MR; Ward PA
    J Exp Med; 2006 Jan; 203(1):53-61. PubMed ID: 16380509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Complement and Histones in Sepsis.
    Zetoune FS; Ward PA
    Front Med (Lausanne); 2020; 7():616957. PubMed ID: 33425963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement as a Major Inducer of Harmful Events in Infectious Sepsis.
    Fattahi F; Zetoune FS; Ward PA
    Shock; 2020 Nov; 54(5):595-605. PubMed ID: 32187106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement and sepsis-induced heart dysfunction.
    Fattahi F; Ward PA
    Mol Immunol; 2017 Apr; 84():57-64. PubMed ID: 27931779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of the C5a Receptor C5aR2 Worsens Ischemic Tissue Injury by Increasing C5aR1-Mediated Neutrophil Infiltration.
    Wu MCL; Lee JD; Ruitenberg MJ; Woodruff TM
    J Immunol; 2020 Nov; 205(10):2834-2839. PubMed ID: 33028618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement C5a Functions as a Master Switch for the pH Balance in Neutrophils Exerting Fundamental Immunometabolic Effects.
    Denk S; Neher MD; Messerer DAC; Wiegner R; Nilsson B; Rittirsch D; Nilsson-Ekdahl K; Weckbach S; Ignatius A; Kalbitz M; Gebhard F; Weiss ME; Vogt J; Radermacher P; Köhl J; Lambris JD; Huber-Lang MS
    J Immunol; 2017 Jun; 198(12):4846-4854. PubMed ID: 28490576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement C5a Receptor 1 Exacerbates the Pathophysiology of
    Herrmann JB; Muenstermann M; Strobel L; Schubert-Unkmeir A; Woodruff TM; Gray-Owen SD; Klos A; Johswich KO
    mBio; 2018 Jan; 9(1):. PubMed ID: 29362231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of C5a-C5aR interaction in sepsis.
    Guo RF; Riedemann NC; Ward PA
    Shock; 2004 Jan; 21(1):1-7. PubMed ID: 14676676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.
    Colley CS; Popovic B; Sridharan S; Debreczeni JE; Hargeaves D; Fung M; An LL; Edwards B; Arnold J; England E; Eghobamien L; Sivars U; Flavell L; Renshaw J; Wickson K; Warrener P; Zha J; Bonnell J; Woods R; Wilkinson T; Dobson C; Vaughan TJ
    MAbs; 2018 Jan; 10(1):104-117. PubMed ID: 28952876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement Destabilizes Cardiomyocyte Function In Vivo after Polymicrobial Sepsis and In Vitro.
    Kalbitz M; Fattahi F; Herron TJ; Grailer JJ; Jajou L; Lu H; Huber-Lang M; Zetoune FS; Sarma JV; Day SM; Russell MW; Jalife J; Ward PA
    J Immunol; 2016 Sep; 197(6):2353-61. PubMed ID: 27521340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of C5 activation products in sepsis.
    Ward PA
    ScientificWorldJournal; 2010 Dec; 10():2395-402. PubMed ID: 21170490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The harmful role of c5a on innate immunity in sepsis.
    Ward PA
    J Innate Immun; 2010; 2(5):439-45. PubMed ID: 20588003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis.
    Riedemann NC; Guo RF; Hollmann TJ; Gao H; Neff TA; Reuben JS; Speyer CL; Sarma JV; Wetsel RA; Zetoune FS; Ward PA
    FASEB J; 2004 Feb; 18(2):370-2. PubMed ID: 14688199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the C5a-C5a receptor axis in the inflammatory responses of the lungs after experimental polytrauma and hemorrhagic shock.
    Chakraborty S; Winkelmann VE; Braumüller S; Palmer A; Schultze A; Klohs B; Ignatius A; Vater A; Fauler M; Frick M; Huber-Lang M
    Sci Rep; 2021 Jan; 11(1):2158. PubMed ID: 33495506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Complement C5a Receptor 1 for the Treatment of Immunosuppression in Sepsis.
    Sommerfeld O; Medyukhina A; Neugebauer S; Ghait M; Ulferts S; Lupp A; König R; Wetzker R; Schulz S; Figge MT; Bauer M; Press AT
    Mol Ther; 2021 Jan; 29(1):338-346. PubMed ID: 32966769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.